Effects of integrated interventions on transmission risk and care continuum outcomes in persons living with HIV
Towards depersonalized abacavir therapy
In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition
Gut microbiota diversity predicts immune status in HIV-1 infection
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b)
Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men
CD4+ cell dynamics in untreated HIV-1 infection
Once vs. twice-daily lopinavir/ritonavir in HIV-1-infected children
Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks
Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1
Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia
Predicting the extinction of HIV-2 in rural Guinea-Bissau
Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting
Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
The HIV care cascade in Switzerland
Molecular analysis allows inference into HIV transmission among young men who have sex with men in the United States
HIV treatment cascades
Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo
Renal dysfunction among HIV-infected patients starting antiretroviral therapy in Mwanza, Tanzania
Renal dysfunction and schistosomiasis among HIV-infected patients starting antiretroviral therapy in Mwanza, Tanzania
Should prophylaxis for Pneumocystis jirovecii pneumonia be considered in patients with a CD4+ count higher than 200 cells/μl?
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1